AI test for weak heart pump using ECG
Part of Heart & circulation clinical trials.
This trial tests whether an artificial intelligence (AI) program can detect a weak heart pump (left ventricular dysfunction) using a standard ECG test. It aims to see if the AI can spot problems early, possibly avoiding the need for an ultrasound.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had an ECG (a heart electrical test) and an echocardiogram (heart ultrasound) within 7 days of each other.
- Your echocardiogram must include a measurement of LVEF (left ventricular ejection fraction, a key measure of heart pumping strength).
- Your ECG recording must be complete, with no missing signals.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence (computer) tool that looks at your ECG (heart tracing) to help detect abnormal heart electrical patterns and the risk of dangerous rhythm problems. You may be helping clinicians screen for rhythm risk using ECG data.
This trial uses an AI tool to analyze your ECG (heart tracing) to detect low pumping function. It may help find hidden heart issues early, especially if you haven't had a recent heart ultrasound.
This trial uses artificial intelligence to analyze your ECG to see if you might be at risk for needing a heart device like a pacemaker. It's a way to check your heart health early.
This trial is testing a new way to check for heart valve problems using your recent ECG (heart electrical test). If you're 60 to 85 and haven't had recent heart imaging or known valve disease, you may qualify.
This study tests whether an artificial intelligence system can detect a weakened heart pump using an ECG (heart rhythm test). If successful, it could help doctors diagnose heart problems faster and more easily.
This study uses an AI tool to look at your ECG (a simple heart test) to help find early signs of atrial fibrillation (an irregular heartbeat) or structural heart disease (changes in heart structure). It aims to see if the AI can help doctors catch these conditions sooner, even in people who don't yet have symptoms.
Hear when a new Cardiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.